Introduction: Bacterial resistance is growing because of treatment a broad spectrum antibio- tics. Gram-negative pathogens which producing carbapenemase are a one of major problem in many hospitals. Rapid detection those strains provide an early inhibition of infection and control the expansion of microorganisms. The aim of work was to characterize the frequency of appearance MBLs in specific groups of Gram-negative bacilli which are resistant or intermediate to at least one of carbapenems.
Methods: Bacterial isolates were collected from Baby Jesus Clinical Hospital from 2003 to 2009. Pathogens were isolated from urine, blood, fluids, swab of the wound, pharyngeal swab. They were identified by the ID 32 E (bioMérieux, France) and Vitek2. Antimicrobial resistance was marked by the ATB G-5 and ATB UR (bioMérieux, France). Detection of metalo-beta-lactamases was tested by disk diffusion test recommended by the EUCAST. The DDS test using imipenem, ceftazidime, ethylenediaminetetraacetic acid (EDTA) and 2-mercaptopropionic acid (2-MPA). Positive test was reading as enlargement of inhibition zone about imipenem- or ceftazidime-impregnated disk.
Results: Of the 88 isolates, 32 come fromEnterobacteriaceae and 56 from non-fermentative bacilli. All strains were tested of production of MBL by disk diffusion test. This method used two inhibitors: ethylenediaminetetraacetic acid and 2-mercaptopropionic acid. As a result of EDTA there was 45 MBL positive strains. In apply 2-MPA there was 55 MBL positive strains. Both the EDTA and 2-MPA disk test showing the highest percentage of positive result in Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and Pseudomonas putida.
Conclusions: Resistance to carbapenems in the non-fermentative bacilli occurs more often than in the Enterobacteriaceae. Method with 2-mercaptopropionic acid was more effective to detect metallo-beta-lactamases than EDTA. Concerns especially bacilli from Enterobacteriaceae.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
cellulitis: case report and mini-review.
New Microbes New Infect
December 2024
Service of Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Background: is a gram-negative, non-fermentative, oxidase-positive, catalase-positive bacillus. has been identified in urinary tract infections, respiratory tract infections, spontaneous peritonitis, septic arthritis, meningitis, bacteraemia and septic shock. Ours is the second case of skin and soft tissue infection sustained by (a case of necrotizing fasciitis with septic shock has been previously reported).
View Article and Find Full Text PDFCentral line-associated bloodstream infection outbreak related to Ralstonia pickettii-contaminated saline in a pediatric hematopoietic stem cell transplant center.
Turk J Pediatr
October 2024
Department of Pediatric Hematology, School of Medicine, Göztepe Medical Park Training and Education Hospital, Bahçeşehir University, İstanbul, Türkiye.
Background: Ralstonia pickettii is an aerobic Gram-negative non-fermentative bacillus. It is an opportunistic pathogen that has recently prompted nosocomial outbreaks. Although it has low virulence, it can cause a wide range of invasive diseases in immunosuppressive patients.
View Article and Find Full Text PDFOptimizing Antibiotic Therapy for Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach.
Antibiotics (Basel)
June 2024
Bioaraba Health Research Institute, 01009 Vitoria-Gasteiz, Spain.
Article Synopsis
- The study investigates the effectiveness of various antibiotics against a multidrug-resistant Gram-negative bacillus in critically ill patients, using a pharmacokinetic/pharmacodynamic (PK/PD) framework.
- Antibiotics evaluated included cotrimoxazole, levofloxacin, minocycline, tigecycline, cefiderocol, and a new combination of aztreonam/avibactam, with Monte Carlo simulations used to assess treatment probabilities and outcomes.
- Findings suggested that cefiderocol, minocycline, tigecycline, and aztreonam/avibactam were promising treatments, but revealed inconsistencies between established PK/PD breakpoints and clinical guidelines, especially depending on isolation location.
Antibacterial activity of gallic acid and methyl gallate against emerging non-fermenting bacilli.
Folia Microbiol (Praha)
June 2024
Departamento de Microbiología, Facultad de Medicina y Hospital Universitario "Dr, José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero, Mitras Centro, 64460, Monterrey, Mexico.
Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cenocepacia are considered emerging pathogens classified as a public health problem due to extensive antimicrobial resistance. Therefore, the discovery of new therapeutic strategies has become crucial. This study aimed to evaluate the antimicrobial activity of gallic acid and methyl gallate against non-fermenting bacteria.
View Article and Find Full Text PDFControlling the hospital aquatic reservoir of multidrug-resistant organisms: a cross-sectional study followed by a nested randomized trial of sink decontamination.
Clin Microbiol Infect
August 2024
Infection Control Programme and World Health Organization Collaborating Centre on Infection Prevention and Control and Antimicrobial Resistance, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Objectives: The hospital water environment is an important reservoir of multidrug-resistant organisms (MDROs) and presents a risk for patient safety. We assessed the effectiveness of thermal and chemical interventions on sinks contaminated with MDRO in the hospital setting.
Methods: We conducted a cross-sectional assessment of MDRO contamination of sinks and toilets in 26 clinical wards of a tertiary care hospital.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!